Pilulka Lekarny AS (XPRA:PINK) Other Stockholders Equity: Kč0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:PINK Pilulka Lekarny AS XPRA:PINK
50 GF Score
Price Kč110.00
GF Value Kč112.19
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS Other Stockholders Equity?

Pilulka Lekarny AS XPRA:PINK +2.80% 50 Other Stockholders Equity is Kč0 Mil as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 50/100 and a GF Value™ of Kč112.19 (Fairly Valued). The stock has 6 warning signs investors should review.

Pilulka Lekarny AS's Other Stockholders Equity for the quarter that ended in Dec. 2025 was Kč0 Mil.

Pilulka Lekarny AS's quarterly Other Stockholders Equity increased from Jun. 2024 (Kč0 Mil) to Dec. 2024 (Kč0 Mil) but then declined from Dec. 2024 (Kč0 Mil) to Dec. 2025 (Kč0 Mil).

Pilulka Lekarny AS's annual Other Stockholders Equity increased from Dec. 2023 (Kč0 Mil) to Dec. 2024 (Kč0 Mil) but then declined from Dec. 2024 (Kč0 Mil) to Dec. 2025 (Kč0 Mil).

Pilulka Lekarny AS Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS Other Stockholders Equity Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 0.00 -0.00 0.00 0.00 0.00

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
Other Stockholders Equity Get a 7-Day Free Trial -0.00 0.00 0.00 0.00 0.00
XPRA:PINK
50GF Score
Pilulka Lekarny AS XPRA:PINK
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of Kč0 Mil mean?
Pilulka Lekarny AS (XPRA:PINK) has a Other Stockholders Equity of Kč0 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Pilulka Lekarny AS and its competitors.
Is Pilulka Lekarny AS's Other Stockholders Equity too high?
Pilulka Lekarny AS's current Other Stockholders Equity is Kč0 Mil. Overall, Pilulka Lekarny AS has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Other Stockholders Equity compare to competitors?
Pilulka Lekarny AS's Other Stockholders Equity of Kč0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Pilulka Lekarny AS and its competitors. Pilulka Lekarny AS's current Other Stockholders Equity is Kč0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč112.19, compared to a current price of Kč110.00 — trading 2% below its estimated fair value. The current Other Stockholders Equity is Kč0 Mil. Pilulka Lekarny AS's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Other Stockholders Equity is Kč0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be undervalued. The current stock price of Kč110.00 is trading 2% below its estimated GF Value™ of Kč112.19. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • Other Stockholders Equity: Kč0 Mil
  • GF Value™: Kč112.19 vs. price of Kč110.00 (2% below fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
50GF Score

Get the complete analysis for XPRA:PINK

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč110.00
Price
Kč112.19
GF Value